Company Filing History:
Years Active: 2000-2008
Title: David H Ostrow: Innovator in Antibody Technology
Introduction
David H Ostrow is a notable inventor based in Lake Zurich, IL (US). He has made significant contributions to the field of biotechnology, particularly in the development of antibodies and their applications in medical diagnostics and therapeutics. With a total of 2 patents, Ostrow's work has the potential to impact various aspects of healthcare.
Latest Patents
Ostrow's latest patents include innovative technologies that focus on erythropoietin receptor binding antibodies. This invention relates to antibodies and antibody fragments that bind to and activate the erythropoietin receptor. The technology also encompasses methods for modulating the endogenous activity of this receptor in mammals, utilizing the developed antibodies and pharmaceutical compositions. Another significant patent involves reagents designed for use as calibrators and controls in diagnostic kits. This invention details a reagent that binds specifically to a predetermined ligand and is uniform in specificity and affinity, which can be produced continually for use in various assays.
Career Highlights
David H Ostrow is currently associated with Abbott Laboratories Corporation, a leading company in the healthcare sector. His work at Abbott has allowed him to focus on advancing antibody technology and its applications in diagnostics and therapeutics. His contributions have been instrumental in enhancing the understanding and utility of antibodies in medical science.
Collaborations
Ostrow has collaborated with notable colleagues, including John R Hackett, Jr and Jane A Hoff. These collaborations have fostered a productive environment for innovation and have contributed to the successful development of his patented technologies.
Conclusion
David H Ostrow's work exemplifies the importance of innovation in biotechnology. His patents reflect a commitment to advancing medical science through the development of novel antibody technologies. His contributions are poised to make a lasting impact on healthcare and diagnostics.